Advertisement
Screener

KYMERA THERAPEUTICS, INC. (KYMR) Patents: Active

KYMERA THERAPEUTICS, INC. Active Patents

47 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2024-03-12: Application 18602701; Invention PROTEIN DEGRADERS AND USES THEREOF; Applicant Kymera Therapeutics, Inc.; Status Patented Case.
  • 2023-09-01: Application 18459675; Invention IRAK4 DEGRADERS AND USES THEREOF; Applicant Kymera Therapeutics, Inc.; Status Patented Case.
  • 2023-07-27: Application 18360277; Invention IRAK DEGRADERS AND USES THEREOF; Applicant Kymera Therapeutics, Inc.; Status Patented Case.
  • 2023-07-19: Application 18355194; Invention IRAK DEGRADERS AND USES THEREOF; Applicant Kymera Therapeutics, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2024-03-1218602701PROTEIN DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2026-01-0612516068US20250145636A1
Nello MAINOLFI
Nan ji
Arthur F. Kluge
United States
United States
United States
ANDERSON, REBECCA L
2023-09-0118459675IRAK4 DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2025-12-1612497402US20230405012A1
Haojing RONG
Bradley ENERSON
United States
United States
LEESER, ERICH A
2023-07-2718360277IRAK DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2026-02-0312539295US20240131016A1
Matthew M. WEISS
United States
MILLIGAN, ADAM C
2023-07-1918355194IRAK DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2025-03-2512258341US20240239777A1
Nello Mainolfi
Nan Ji
Arthur F. Kluge
Matthew M. Weiss
Yi Zhang
Xiaozhang Zheng
United States
United States
United States
United States
United States
United States
ROZOF, TIMOTHY R
2023-06-0618265604SMARCA DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2026-04-2112606568US20250109138A1
Yi ZHANG
Xiaozhang ZHENG
Xiao ZHU
United States
United States
United States
NESTOR, DONNA MICHELLE
2023-04-2418305911IRAK DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2024-12-1712168057US20230398223A1
Nello MAINOLFI
Nan JI
Arthur F. KLUGE
Matthew M. WEISS
Yi ZHANG
United States
United States
United States
United States
United States
VAJDA, KRISTIN ANN
2023-01-3118162365IRAK DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2024-09-1712091411US20230365562A1
Nello MAINOLFI
Chris DE SAVI
Matthew M. WEISS
Xiao ZHU
Xiaozhang ZHENG
Bruce C. FOLLOWS
United States
United States
United States
United States
United States
United States
HEASLEY, MEGHAN CHRISTINE
2022-12-0218008083DEUTERATED IRAK DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2026-06-1612655159US20230250110A1
Xiaozhang ZHENG
United States
RAHMANI, NILOOFAR
2022-11-2818059232CRBN LIGANDS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2024-03-1911932635US20230234950A1
Nello MAINOLFI
Nan JI
Arthur F. KLUGE
United States
United States
United States
RAO, DEEPAK R
2022-10-2818050883IRAK4 DEGRADERS AND SYNTHESIS THEREOFKymera Therapeutics, Inc.Patented Case2025-01-0712187744US20230257399A1
William LEONG
Dharyl Charles WILSON
United States
United Kingdom
STOCKTON, LAURA LYNNE
2022-10-1018045394IRAK DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2023-07-2511707457US20230144292A1
Matthew M. WEISS
United States
NORTHINGTON DAVIS, ZINNA
2022-10-1018045390STAT DEGRADERS AND USES THEREOFKymera Therapeutics, IncPatented Case2023-09-0511746120US20230120381A1
Nello MAINOLFI
Nan JI
Bin YANG
Yi ZHANG
United States
United States
United States
United States
CHEN, PO-CHIH
2022-10-1017963032MDM2 DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2024-03-1911932624US20240025878A1
Nan JI
Matthew M. WEISS
Xiaozhang ZHENG
Xiao ZHU
United States
United States
United States
United States
HABTE, KAHSAY
2022-09-1617912416MDM2 DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2026-01-2012528785US20240424110A1
Nan JI
Matthew M. WEISS
Xiaozhang ZHENG
Xiao ZHU
United States
United States
United States
United States
HABTE, KAHSAY
2022-08-1817890847PROTEIN DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2024-06-1112006329US20230295180A1
Nello Mainolfi
Nan Ji
Arthur F. Kluge
United States
United States
United States
ANDERSON, REBECCA L
2022-06-2317788624SMARCA INHIBITORS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2026-03-1012569485US20230103415A1
Yi ZHANG
Paul R. FLEMING
Xiao ZHU
United States
United States
United States
BURKETT, DANIEL JOHN
2022-06-1017837449PROTEIN DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2026-08-2512715877US20230115184A1
Nello MAINOLFI
Nan Ji
Yi Zhang
Matthew M. Weiss
United States
United States
United States
United States
CHICKS, ASHLI ARIANA
2022-06-1017784401IRAK DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2026-02-1712551564US20230190940A1
Yi ZHANG
Xiaozhang ZHENG
Xiao ZHU
United States
United States
United States
SEITZ, ANTHONY JOSEPH
2022-05-1117741890CRBN LIGANDS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2026-02-0312540127US20230038512A1
Nello MAINOLFI
Nan JI
Yi ZHANG
Matthew M. WEISS
United States
United States
United States
United States
SEAMAN, D MARGARET M
2022-05-0617738556CDK2 DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2024-09-2412097261US20230110180A1
Xiaozhang ZHENG
Yi ZHANG
Robert AVERSA
Xiao ZHU
Philip COLLIER
United States
United States
United States
United States
United States
VAJDA, KRISTIN ANN
2022-05-0417736669STAT DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2024-09-0312077555US20230084113A1
Nello MAINOLFI
Nan Ji
Bin Yang
Yi Zhang
United States
United States
United States
United States
CHEN, PO-CHIH
2022-02-2417679496TRICYCLIC CRBN LIGANDS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2024-02-1311897882US20220306631A1
Nan JI
Arthur F. KLUGE
Matthew M. WEISS
Yi ZHANG
United States
United States
United States
United States
RAO, DEEPAK R
2022-02-1517651202IRAK4 DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2023-10-0311773103US20220274993A1
Haojing RONG
Brad ENERSON
United States
United States
LEESER, ERICH A
2022-02-1517651201IRAK4 DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2024-12-2412171768US20220273668A1
Jared GOLLOB
Jeffrey DAVIS
Alice MCDONALD
Haojing RONG
United States
United States
United States
United States
CRAIGO, WILLIAM A
2022-02-1417650871IRAK DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2023-11-0711807636US20220324854A1
Nello MAINOLFI
Nan Ji
Arthur F. Kluge
Matthew M. Weiss
Yi Zhang
Xiaozhang Zheng
United States
United States
United States
United States
United States
United States
ROZOF, TIMOTHY R
2022-02-1017650545IRAK DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2023-08-1511723980US20230106066A1
Nello MAINOLFI
Nan Ji
Arthur F. Kluge
Matthew M. Weiss
Yi Zhang
United States
United States
United States
United States
United States
VAJDA, KRISTIN ANN
2022-01-1417597638IRAK DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2026-02-2412558427US20230132715A1
Nan JI
Michael D. SINTCHAK
Yi ZHANG
Xiaozhang ZHENG
United States
United States
United States
United States
MAHLUM, JONATHAN DAVIS
2021-12-3017646556IRAK DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2024-11-2612150995US20230101353A1
Nello Mainolfi
Nan Ji
Matthew M. Weiss
Xiaozhang Zheng
Yi Zhang
Paul R. Fleming
Xiao Zhu
United States
United States
United States
United States
United States
United States
United States
CHANDRAKUMAR, NIZAL S
2021-12-2817597165IRAK DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2026-02-1012545659US20230069104A1
Nello MAINOLFI
Nan JI
Matthew M. WEISS
Xiaozhang ZHENG
Yi ZHANG
Paul R. FLEMING
United States
United States
United States
United States
United States
United States
SHIM, DAVID M.
2021-12-1017596490SMARCA DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2026-01-1312521438US20230149549A1
Nan JI
Yi ZHANG
Michael D. SINTCHAK
Paul R. FLEMING
United States
United States
United States
United States
NESTOR, DONNA MICHELLE
2021-12-1017596488SMARCA DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2026-05-1212624044US20230072658A1
Nan JI
Yi ZHANG
Matthew M. WEISS
Paul R. Fleming
United States
United States
United States
United States
HASTINGS, ALISON AZAR
2021-07-2917444015METHODS OF TREATING MUTANT LYMPHOMASKymera Therapeutics, Inc.Patented Case2024-01-0211857535US20220054453A1
Duncan Walker
United States
JACKSON, SHAWQUIA
2021-06-0317338420CRYSTALLINE FORMS OF IRAK DEGRADERSKymera Therapeutics, Inc.Patented Case2023-06-2711685750US20210395273A1
Xiaozhang Zheng
Don Corson
United States
United States
MAURO, JOHN MATTHEW
2021-01-0617258339PROTEIN DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2025-10-2812454520US20220348556A1
Yi ZHANG
Nan JI
Arthur F. KLUGE
Matthew M. WEISS
United States
United States
United States
United States
SAEED, KAMAL A
2020-12-2317132764SMARCA DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2023-06-2011679109US20220331317A1
Yi ZHANG
Paul R. FLEMING
Xiao ZHU
United States
United States
United States
JACKSON, SHAWQUIA
2020-12-1717125934IRAK DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2023-02-2811591332US20220340570A1
Matthew M. WEISS
Xiaozhang ZHENG
Xiao ZHU
United States
United States
United States
AULAKH, CHARANJIT
2020-12-1717125426IRAK DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2023-10-1011779578US20210228562A1
Matthew M. WEISS
United States
NORTHINGTON DAVIS, ZINNA
2020-10-1617073019IRAK DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2022-05-0311318205
Nello Mainolfi
Nan Ji
Arthur F. Kluge
Matthew M. Weiss
Yi Zhang
United States
United States
United States
United States
United States
VAJDA, KRISTIN ANN
2020-09-1817025774IRAK DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2021-09-1411117889
Nello Mainolfi
Nan Ji
Arthur F. Kluge
Matthew M. Weiss
Yi Zhang
Xiaozhang Zheng
United States
United States
United States
United States
United States
United States
ROZOF, TIMOTHY R
2020-07-1016961366PROTEIN DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2022-11-0111485743US20210002296A1
Nello Mainolfi
Nan Ji
Arthur F. Kluge
United States
United States
United States
ANDERSON, REBECCA L
2020-07-1016961362CRBN LIGANDS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2022-11-2911512080US20200347045A1
Nello Mainolfi
Nan Ji
Arthur F. Kluge
United States
United States
United States
RAO, DEEPAK R
2020-04-0616841095STAT DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2022-11-0111485750
Nello Mainolfi
Nan Ji
Bin Yang
Yi Zhang
United States
United States
United States
United States
CHEN, PO-CHIH
2020-03-2316649732PROTEIN DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2023-04-1111623932US20210238193A1
Nello Mainolfi
Nan Ji
Yi Zhang
Matthew M. Weiss
United States
United States
United States
United States
MAURO, JOHN MATTHEW
2020-03-2316649717CRBN LIGANDS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2022-06-1411358948US20200377469A1
Nello Mainolfi
Nan Ji
Yi Zhang
Matthew M. Weiss
United States
United States
United States
United States
JEAN-LOUIS, SAMIRA JM
2019-12-0216701077IRAK DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2022-06-0711352350US20210323952A1
Nello Mainolfi
Nan Ji
Arthur F. Kluge
Matthew M. Weiss
Yi Zhang
Xiaozhang Zheng
United States
United States
United States
United States
United States
United States
ROZOF, TIMOTHY R
2019-07-0316502529TRICYCLIC CRBN LIGANDS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2022-04-0511292792US20200010468A1
Nan Ji
Arthur F. Kluge
Matthew M. Weiss
Yi Zhang
United States
United States
United States
United States
RAO, DEEPAK R
2018-12-2116230792IRAK DEGRADERS AND USES THEREOFKymera Therapeutics, Inc.Patented Case2020-12-2910874743US20190192668A1
Nello Mainolfi
Nan Ji
Arthur F. Kluge
Matthew M. Weiss
Yi Zhang
United States
United States
United States
United States
United States
VAJDA, KRISTIN ANN

Similar stocks

Stock NameCountryMarket CapPE Ratio
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
REPLIGEN CORP (RGEN)United States$10.755B185.31
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
Immunovant, Inc. (IMVT)United States$7.028B-14.78
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
CG Oncology, Inc. (CGON)United States$6.095B-27.95
Scholar Rock Holding Corp (SRRK)United States$5.920B-16.37